Cibiem Appoints Ken Martin as President and Chief Executive Officer

  Cibiem Appoints Ken Martin as President and Chief Executive Officer

      Company Strengthens Executive Team to Support Rapid Development of
   Catheter-Based Approach to Treating Sympathetic Nervous System-Mediated
                                   Diseases

Business Wire

NEW YORK -- March 12, 2013

Cibiem, Inc., a medical device company leveraging its proprietary, minimally
invasive, catheter-based approach focused on Carotid Body Modulation™ (CBM)
for the treatment of a broad range of sympathetic nervous system-mediated
diseases, today announced the appointment of Ken Martin to president and chief
executive officer. Mr. Martin will succeed Cibiem co-founder Howard R. Levin,
M.D., who will continue his active involvement within the company and as a
member of its board of directors.

“We are excited to welcome Ken to Cibiem as he brings more than 20 years of
experience and an impressive track record in leading successful medical device
companies through commercialization and valuable strategic acquisitions,” said
Dr. Levin. “Since our $10 million Series A financing last year, Cibiem has
made significant, rapid progress in advancing our CBM program, including
continued enrollment in our first-in-man clinical trial. With Ken’s expertise
in technology development and product engineering of catheter-based medical
devices, we are in an even stronger position as we move forward with the
development of our catheter-based approach for the treatment of diseases such
as hypertension, heart failure, diabetes and renal failure.”

Prior to joining Cibiem, Mr. Martin was president and chief executive officer
of Sadra Medical. There, he worked with the founding team to significantly
redesign the company’s Lotus™ Valve System, the first fully repositionable
device for percutaneous aortic valve replacement to treat patients with severe
aortic stenosis, which ultimately led to the company’s acquisition by Boston
Scientific Corp. for $450 million in 2011. Prior to joining Sadra Medical, Mr.
Martin was vice president of engineering at Hansen Medical, a robotic catheter
control system company, and at Immersion Corporation, a pioneer in haptic
feedback systems used for simulation and hands-on medical training. Prior to
that, he was an engineer at IDEO, a product design and innovation consulting
firm. Mr. Martin is an inventor or co-inventor on more than 50 issued patents
and published patent applications and is an alumna of the Stanford Biodesign
Program. Mr. Martin holds a B.A.Sc. in mechanical engineering from the
University of Toronto, an M.S. in manufacturing systems engineering from
Stanford University and an M.B.A. from Santa Clara University.

“Modulation of the carotid body is an innovative and exciting approach to
treating sympathetic nervous system-mediated diseases, and Cibiem has a
significant competitive advantage as the only company currently targeting
CBM,” said Mr. Martin. “Having launched five other successful companies to
date, including the game-changing Ardian, Cibiem’s co-founders are proven idea
generators and innovators in solving medical challenges by addressing the root
cause of disease. I am excited to work with Howard and Mark Gelfand and look
forward to leading the exceptional Cibiem team as we execute on their vision
and advance this transformative approach.”

About Cibiem

Cibiem is a medical device company leveraging its proprietary, minimally
invasive, catheter-based approach focused on Carotid Body Modulation™ (CBM)
for the treatment of sympathetic nervous system-mediated diseases such as
hypertension, heart failure, diabetes and renal failure. Based in New York
City, the company was co-founded by Mark Gelfand and Howard R. Levin, M.D.,
the proven team of innovators and entrepreneurs behind Coridea, a technology
incubator focused on medical device innovation driven by new targets in the
cardio-renal and cardio-pulmonary fields. The company is backed by top-tier
venture investors SV Life Sciences and Third Rock Ventures. For more
information, please visit www.cibiem.com.

Contact:

Pure Communications, Inc.
Katie Wilson, 910-509-3977
katie@purecommunicationsinc.com
 
Press spacebar to pause and continue. Press esc to stop.